smithkline beecham limited
smithkline beecham limited Company Information
Company Number
02337959
Next Accounts
Sep 2025
Shareholders
glaxosmithkline finance plc
Group Structure
View All
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
+1Registered Address
79 new oxford street, london, WC1A 1DG
Website
http://gsk.comsmithkline beecham limited Estimated Valuation
Pomanda estimates the enterprise value of SMITHKLINE BEECHAM LIMITED at £238.4m based on a Turnover of £140m and 1.7x industry multiple (adjusted for size and gross margin).
smithkline beecham limited Estimated Valuation
Pomanda estimates the enterprise value of SMITHKLINE BEECHAM LIMITED at £249.9m based on an EBITDA of £35m and a 7.14x industry multiple (adjusted for size and gross margin).
smithkline beecham limited Estimated Valuation
Pomanda estimates the enterprise value of SMITHKLINE BEECHAM LIMITED at £2.1b based on Net Assets of £1.3b and 1.54x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Smithkline Beecham Limited Overview
Smithkline Beecham Limited is a live company located in london, WC1A 1DG with a Companies House number of 02337959. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in January 1989, it's largest shareholder is glaxosmithkline finance plc with a 100% stake. Smithkline Beecham Limited is a mature, mega sized company, Pomanda has estimated its turnover at £140m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Smithkline Beecham Limited Health Check
Pomanda's financial health check has awarded Smithkline Beecham Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
5 Strong
0 Regular
4 Weak
Size
annual sales of £140m, make it larger than the average company (£27.9m)
£140m - Smithkline Beecham Limited
£27.9m - Industry AVG
Growth
3 year (CAGR) sales growth of -1%, show it is growing at a slower rate (7.8%)
-1% - Smithkline Beecham Limited
7.8% - Industry AVG
Production
with a gross margin of 10.7%, this company has a higher cost of product (37.4%)
10.7% - Smithkline Beecham Limited
37.4% - Industry AVG
Profitability
an operating margin of 13.6% make it more profitable than the average company (5.7%)
13.6% - Smithkline Beecham Limited
5.7% - Industry AVG
Employees
with 605 employees, this is above the industry average (107)
605 - Smithkline Beecham Limited
107 - Industry AVG
Pay Structure
on an average salary of £77.7k, the company has a higher pay structure (£56.2k)
£77.7k - Smithkline Beecham Limited
£56.2k - Industry AVG
Efficiency
resulting in sales per employee of £231.4k, this is less efficient (£318.3k)
£231.4k - Smithkline Beecham Limited
£318.3k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Smithkline Beecham Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Smithkline Beecham Limited
- - Industry AVG
Stock Days
it holds stock equivalent to 17 days, this is less than average (71 days)
17 days - Smithkline Beecham Limited
71 days - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Smithkline Beecham Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 49.8%, this is a lower level of debt than the average (57.2%)
49.8% - Smithkline Beecham Limited
57.2% - Industry AVG
SMITHKLINE BEECHAM LIMITED financials
Smithkline Beecham Limited's latest turnover from December 2023 is £140 million and the company has net assets of £1.3 billion. According to their latest financial statements, Smithkline Beecham Limited has 605 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 140,000,000 | 121,000,000 | 111,000,000 | 144,000,000 | 463,000,000 | 291,000,000 | 356,000,000 | 324,000,000 | 381,000,000 | 503,000,000 | 591,000,000 | 487,000,000 | 627,000,000 | 815,000,000 | 918,000,000 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 125,000,000 | 108,000,000 | 102,000,000 | 170,000,000 | 420,000,000 | 265,000,000 | 326,000,000 | 296,000,000 | 362,000,000 | 423,000,000 | 484,000,000 | 404,000,000 | 538,000,000 | 692,000,000 | 830,000,000 |
| Gross Profit | 15,000,000 | 13,000,000 | 9,000,000 | -26,000,000 | 43,000,000 | 26,000,000 | 30,000,000 | 28,000,000 | 19,000,000 | 80,000,000 | 107,000,000 | 83,000,000 | 89,000,000 | 123,000,000 | 88,000,000 |
| Admin Expenses | -4,000,000 | 4,000,000 | -1,000,000 | -39,000,000 | -22,000,000 | -11,000,000 | -9,000,000 | 5,000,000 | -62,000,000 | 52,000,000 | 39,000,000 | 69,000,000 | 52,000,000 | 53,000,000 | 57,000,000 |
| Operating Profit | 19,000,000 | 9,000,000 | 10,000,000 | 13,000,000 | 65,000,000 | 37,000,000 | 39,000,000 | 23,000,000 | 81,000,000 | 28,000,000 | 68,000,000 | 14,000,000 | 37,000,000 | 70,000,000 | 31,000,000 |
| Interest Payable | 86,000,000 | 35,000,000 | 7,000,000 | 42,000,000 | 94,000,000 | 43,000,000 | 5,000,000 | 6,000,000 | 2,000,000 | 1,000,000 | 3,000,000 | 2,000,000 | 12,000,000 | 19,000,000 | |
| Interest Receivable | 26,000,000 | 15,000,000 | 31,000,000 | 88,000,000 | 12,000,000 | 1,000,000 | 2,000,000 | 2,000,000 | |||||||
| Pre-Tax Profit | -41,000,000 | -11,000,000 | 3,000,000 | 2,000,000 | 59,000,000 | 6,000,000 | 35,000,000 | 19,000,000 | 81,000,000 | 46,000,000 | 127,000,000 | 40,000,000 | 121,000,000 | 10,884,000,000 | 95,000,000 |
| Tax | 11,000,000 | 1,000,000 | 17,000,000 | -2,000,000 | -8,000,000 | -14,000,000 | -13,000,000 | -8,000,000 | -12,000,000 | -9,000,000 | -21,000,000 | -5,000,000 | -14,000,000 | -12,000,000 | -4,000,000 |
| Profit After Tax | -30,000,000 | -10,000,000 | 20,000,000 | 51,000,000 | -8,000,000 | 22,000,000 | 11,000,000 | 69,000,000 | 37,000,000 | 106,000,000 | 35,000,000 | 107,000,000 | 10,872,000,000 | 91,000,000 | |
| Dividends Paid | 4,000,000 | 11,000,000 | 75,000,000 | 11,063,000,000 | |||||||||||
| Retained Profit | -30,000,000 | -10,000,000 | 20,000,000 | 51,000,000 | -12,000,000 | 11,000,000 | 11,000,000 | 69,000,000 | 37,000,000 | 106,000,000 | 35,000,000 | 32,000,000 | -191,000,000 | 91,000,000 | |
| Employee Costs | 47,000,000 | 42,000,000 | 45,000,000 | 65,000,000 | 82,000,000 | 70,000,000 | 110,000,000 | 85,000,000 | 89,000,000 | 117,000,000 | 155,000,000 | 148,000,000 | 143,000,000 | 158,000,000 | 175,000,000 |
| Number Of Employees | 605 | 563 | 641 | 838 | 947 | 1,035 | 1,333 | 1,273 | 1,384 | 2,097 | 2,606 | 2,600 | 2,633 | 2,862 | 3,262 |
| EBITDA* | 35,000,000 | 23,000,000 | 25,000,000 | 30,000,000 | 86,000,000 | 68,000,000 | 142,000,000 | 51,000,000 | 104,000,000 | 61,000,000 | 111,000,000 | 61,000,000 | 86,000,000 | 130,000,000 | 117,000,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 194,000,000 | 189,000,000 | 187,000,000 | 183,000,000 | 218,000,000 | 427,000,000 | 417,000,000 | 470,000,000 | 413,000,000 | 306,000,000 | 334,000,000 | 437,000,000 | 367,000,000 | 378,000,000 | 376,000,000 |
| Intangible Assets | 1,000,000 | 1,000,000 | |||||||||||||
| Investments & Other | 2,405,000,000 | 2,407,000,000 | 2,407,000,000 | 2,387,000,000 | 1,144,000,000 | 2,178,000,000 | 1,106,000,000 | 1,090,000,000 | 1,098,000,000 | 1,137,000,000 | 1,135,000,000 | 1,122,000,000 | 1,131,000,000 | 1,147,000,000 | 2,725,000,000 |
| Debtors (Due After 1 year) | 6,000,000 | ||||||||||||||
| Total Fixed Assets | 2,600,000,000 | 2,597,000,000 | 2,594,000,000 | 2,570,000,000 | 1,362,000,000 | 2,605,000,000 | 1,523,000,000 | 1,560,000,000 | 1,511,000,000 | 1,449,000,000 | 1,469,000,000 | 1,559,000,000 | 1,498,000,000 | 1,525,000,000 | 3,101,000,000 |
| Stock & work in progress | 6,000,000 | 5,000,000 | 6,000,000 | 7,000,000 | 9,000,000 | 51,000,000 | 51,000,000 | 54,000,000 | 74,000,000 | 110,000,000 | 109,000,000 | 124,000,000 | 103,000,000 | 155,000,000 | 214,000,000 |
| Trade Debtors | |||||||||||||||
| Group Debtors | 27,000,000 | 1,161,000,000 | 1,145,000,000 | 1,223,000,000 | 1,203,000,000 | 895,000,000 | 917,000,000 | 736,000,000 | 805,000,000 | 248,000,000 | 274,000,000 | 99,000,000 | 189,000,000 | 155,000,000 | 174,000,000 |
| Misc Debtors | 15,000,000 | 3,000,000 | 5,000,000 | 2,000,000 | 13,000,000 | 1,000,000 | 3,000,000 | 15,000,000 | 6,000,000 | 15,000,000 | 17,000,000 | 21,000,000 | 15,000,000 | 9,000,000 | 13,000,000 |
| Cash | |||||||||||||||
| misc current assets | 1,248,000,000 | 2,000,000 | 2,000,000 | 92,000,000 | |||||||||||
| total current assets | 48,000,000 | 1,169,000,000 | 1,156,000,000 | 1,232,000,000 | 2,473,000,000 | 949,000,000 | 973,000,000 | 805,000,000 | 885,000,000 | 465,000,000 | 400,000,000 | 244,000,000 | 307,000,000 | 319,000,000 | 401,000,000 |
| total assets | 2,648,000,000 | 3,766,000,000 | 3,750,000,000 | 3,802,000,000 | 3,835,000,000 | 3,554,000,000 | 2,496,000,000 | 2,365,000,000 | 2,396,000,000 | 1,914,000,000 | 1,869,000,000 | 1,803,000,000 | 1,805,000,000 | 1,844,000,000 | 3,502,000,000 |
| Bank overdraft | 3,000,000 | 2,000,000 | 2,000,000 | 3,000,000 | 3,000,000 | ||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 64,000,000 | 66,000,000 | 114,000,000 | 108,000,000 | 91,000,000 | 71,000,000 | 52,000,000 | ||||||||
| Group/Directors Accounts | 1,288,000,000 | 2,379,000,000 | 2,346,000,000 | 2,392,000,000 | 2,386,000,000 | 2,164,000,000 | 1,092,000,000 | 996,000,000 | 1,015,000,000 | 596,000,000 | 516,000,000 | 549,000,000 | 605,000,000 | 654,000,000 | 2,110,000,000 |
| other short term finances | 33,000,000 | 7,000,000 | |||||||||||||
| hp & lease commitments | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | |||||||||
| other current liabilities | 27,000,000 | 21,000,000 | 20,000,000 | 32,000,000 | 73,000,000 | 42,000,000 | 64,000,000 | 70,000,000 | 33,000,000 | 35,000,000 | 46,000,000 | 39,000,000 | 42,000,000 | 35,000,000 | 40,000,000 |
| total current liabilities | 1,315,000,000 | 2,400,000,000 | 2,366,000,000 | 2,424,000,000 | 2,459,000,000 | 2,239,000,000 | 1,156,000,000 | 1,066,000,000 | 1,112,000,000 | 698,000,000 | 680,000,000 | 699,000,000 | 741,000,000 | 764,000,000 | 2,213,000,000 |
| loans | 26,000,000 | 28,000,000 | |||||||||||||
| hp & lease commitments | 1,000,000 | 1,000,000 | 2,000,000 | 2,000,000 | 3,000,000 | ||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | 5,000,000 | 3,000,000 | 4,000,000 | 2,000,000 | ||||||
| provisions | 4,000,000 | 6,000,000 | 11,000,000 | 25,000,000 | 23,000,000 | 14,000,000 | 29,000,000 | 9,000,000 | 7,000,000 | 8,000,000 | 19,000,000 | 38,000,000 | 33,000,000 | 54,000,000 | 71,000,000 |
| total long term liabilities | 4,000,000 | 6,000,000 | 11,000,000 | 25,000,000 | 23,000,000 | 14,000,000 | 30,000,000 | 10,000,000 | 8,000,000 | 10,000,000 | 22,000,000 | 43,000,000 | 38,000,000 | 86,000,000 | 104,000,000 |
| total liabilities | 1,319,000,000 | 2,406,000,000 | 2,377,000,000 | 2,449,000,000 | 2,482,000,000 | 2,253,000,000 | 1,186,000,000 | 1,076,000,000 | 1,120,000,000 | 708,000,000 | 702,000,000 | 742,000,000 | 779,000,000 | 850,000,000 | 2,317,000,000 |
| net assets | 1,329,000,000 | 1,360,000,000 | 1,373,000,000 | 1,353,000,000 | 1,353,000,000 | 1,301,000,000 | 1,310,000,000 | 1,289,000,000 | 1,276,000,000 | 1,206,000,000 | 1,167,000,000 | 1,061,000,000 | 1,026,000,000 | 994,000,000 | 1,185,000,000 |
| total shareholders funds | 1,329,000,000 | 1,360,000,000 | 1,373,000,000 | 1,353,000,000 | 1,353,000,000 | 1,301,000,000 | 1,310,000,000 | 1,289,000,000 | 1,276,000,000 | 1,206,000,000 | 1,167,000,000 | 1,061,000,000 | 1,026,000,000 | 994,000,000 | 1,185,000,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 19,000,000 | 9,000,000 | 10,000,000 | 13,000,000 | 65,000,000 | 37,000,000 | 39,000,000 | 23,000,000 | 81,000,000 | 28,000,000 | 68,000,000 | 14,000,000 | 37,000,000 | 70,000,000 | 31,000,000 |
| Depreciation | 16,000,000 | 14,000,000 | 15,000,000 | 17,000,000 | 21,000,000 | 31,000,000 | 103,000,000 | 28,000,000 | 23,000,000 | 33,000,000 | 43,000,000 | 47,000,000 | 49,000,000 | 60,000,000 | 86,000,000 |
| Amortisation | |||||||||||||||
| Tax | 11,000,000 | 1,000,000 | 17,000,000 | -2,000,000 | -8,000,000 | -14,000,000 | -13,000,000 | -8,000,000 | -12,000,000 | -9,000,000 | -21,000,000 | -5,000,000 | -14,000,000 | -12,000,000 | -4,000,000 |
| Stock | 1,000,000 | -1,000,000 | -1,000,000 | -2,000,000 | -42,000,000 | -3,000,000 | -20,000,000 | -36,000,000 | 1,000,000 | -15,000,000 | 21,000,000 | -52,000,000 | -59,000,000 | 214,000,000 | |
| Debtors | -1,122,000,000 | 14,000,000 | -75,000,000 | 9,000,000 | 320,000,000 | -24,000,000 | 169,000,000 | -60,000,000 | 542,000,000 | -22,000,000 | 171,000,000 | -84,000,000 | 40,000,000 | -23,000,000 | 187,000,000 |
| Creditors | -64,000,000 | -2,000,000 | -48,000,000 | 6,000,000 | 17,000,000 | 20,000,000 | 19,000,000 | 52,000,000 | |||||||
| Accruals and Deferred Income | 6,000,000 | 1,000,000 | -12,000,000 | -41,000,000 | 31,000,000 | -22,000,000 | -6,000,000 | 37,000,000 | -2,000,000 | -11,000,000 | 7,000,000 | -3,000,000 | 7,000,000 | -5,000,000 | 40,000,000 |
| Deferred Taxes & Provisions | -2,000,000 | -5,000,000 | -14,000,000 | 2,000,000 | 9,000,000 | -15,000,000 | 20,000,000 | 2,000,000 | -1,000,000 | -11,000,000 | -19,000,000 | 5,000,000 | -21,000,000 | -17,000,000 | 71,000,000 |
| Cash flow from operations | 1,171,000,000 | 7,000,000 | 92,000,000 | -18,000,000 | -160,000,000 | 41,000,000 | -23,000,000 | 98,000,000 | -419,000,000 | 3,000,000 | -72,000,000 | 138,000,000 | 90,000,000 | 197,000,000 | -125,000,000 |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | -2,000,000 | 20,000,000 | 1,243,000,000 | -1,034,000,000 | 1,072,000,000 | 16,000,000 | -8,000,000 | -39,000,000 | 2,000,000 | 13,000,000 | -9,000,000 | -16,000,000 | -1,578,000,000 | 2,725,000,000 | |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -1,091,000,000 | 33,000,000 | -46,000,000 | 6,000,000 | 222,000,000 | 1,072,000,000 | 96,000,000 | -19,000,000 | 419,000,000 | 80,000,000 | -33,000,000 | -56,000,000 | -49,000,000 | -1,456,000,000 | 2,110,000,000 |
| Other Short Term Loans | -33,000,000 | 33,000,000 | -7,000,000 | 7,000,000 | |||||||||||
| Long term loans | -26,000,000 | -2,000,000 | 28,000,000 | ||||||||||||
| Hire Purchase and Lease Commitments | -2,000,000 | 1,000,000 | -2,000,000 | -1,000,000 | 4,000,000 | ||||||||||
| other long term liabilities | -1,000,000 | -1,000,000 | -3,000,000 | 2,000,000 | -1,000,000 | 2,000,000 | 2,000,000 | ||||||||
| share issue | |||||||||||||||
| interest | -60,000,000 | -20,000,000 | -7,000,000 | -11,000,000 | -6,000,000 | -31,000,000 | -4,000,000 | -4,000,000 | -1,000,000 | -3,000,000 | -2,000,000 | -12,000,000 | -19,000,000 | ||
| cash flow from financing | -1,152,000,000 | 10,000,000 | -53,000,000 | -5,000,000 | 184,000,000 | 1,076,000,000 | 102,000,000 | -21,000,000 | 418,000,000 | 81,000,000 | -36,000,000 | -59,000,000 | -78,000,000 | -1,476,000,000 | 3,226,000,000 |
| cash and cash equivalents | |||||||||||||||
| cash | |||||||||||||||
| overdraft | -3,000,000 | 1,000,000 | -1,000,000 | 3,000,000 | |||||||||||
| change in cash | 3,000,000 | -1,000,000 | 1,000,000 | -3,000,000 |
smithkline beecham limited Credit Report and Business Information
Smithkline Beecham Limited Competitor Analysis
Perform a competitor analysis for smithkline beecham limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other mega companies, companies in WC1A area or any other competitors across 12 key performance metrics.
smithkline beecham limited Ownership
SMITHKLINE BEECHAM LIMITED group structure
Smithkline Beecham Limited has 15 subsidiary companies.
Ultimate parent company
2 parents
SMITHKLINE BEECHAM LIMITED
02337959
15 subsidiaries
smithkline beecham limited directors
Smithkline Beecham Limited currently has 5 directors. The longest serving directors include Mr Adam Walker (May 2019) and Mrs Ciara Lynch (Mar 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Adam Walker | England | 57 years | May 2019 | - | Director |
| Mrs Ciara Lynch | England | 56 years | Mar 2020 | - | Director |
| Mr Richard Latchford | 45 years | Sep 2021 | - | Director | |
| Mr Dmytro Oliinyk | United Kingdom | 41 years | Feb 2022 | - | Director |
| Mr Dmytro Oliinyk | United Kingdom | 41 years | Feb 2022 | - | Director |
P&L
December 2023turnover
140m
+16%
operating profit
19m
+111%
gross margin
10.8%
-0.27%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
1.3b
-0.02%
total assets
2.6b
-0.3%
cash
0
0%
net assets
Total assets minus all liabilities
smithkline beecham limited company details
company number
02337959
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
21100 - Manufacture of basic pharmaceutical products
incorporation date
January 1989
age
36
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
smithkline beecham p.l.c. (October 2009)
goldslot public limited company (April 1989)
accountant
-
auditor
DELOITTE LLP
address
79 new oxford street, london, WC1A 1DG
Bank
HSBC BANK PLC
Legal Advisor
-
smithkline beecham limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to smithkline beecham limited. Currently there are 1 open charges and 0 have been satisfied in the past.
smithkline beecham limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SMITHKLINE BEECHAM LIMITED. This can take several minutes, an email will notify you when this has completed.
smithkline beecham limited Companies House Filings - See Documents
| date | description | view/download |
|---|
